David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Animal Ethics 1 (1):37-45 (2011)
In early 2009, President Obama overturned the ban on federal funding for research involving the derivation of human embryonic stem cells (hESC). The Food and Drug Administration (FDA) also approved Geron’s first-in-human hESC trial for spinal cord injury (SCI) patients. We anticipate an increase in both research in the United States to derive hESC and applications to the FDA for approval of clinical trials involving transplantation of hESCs. An increase of such clinical trials will require a concomitant increase in the number of preceding preclinical assays. We examine important issues concerning the use of animals in SCI stem cell research that require a reevaluation of the moral permissibility of studies such as Geron’s.
|Keywords||Animal Ethics Stem Cells Translational research Model validity|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Frederic Bretzner, Frederic Gilbert, Françoise Baylis & Robert M. Brownstone (2011). Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury. Cell Stem Cell 8 (5):468-475.
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
David van Gend (2011). Geron and the Demise of Embryonic Stem Cell Science. Bioethics Research Notes 23 (4):51.
Lawrence Burns (2009). “You Are Our Only Hope”: Trading Metaphorical “Magic Bullets” for Stem Cell “Superheroes”. Theoretical Medicine and Bioethics 30 (6):427-442.
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine and Ethics 38 (2):267-276.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
John D. Loike Moshe Tendler (2008). Reconstituting a Human Brain in Animals: A Jewish Perspective on Human Sanctity. Kennedy Institute of Ethics Journal 18 (4):pp. 347-367.
Joseph J. Fins & Madeleine Schachter (2002). Patently Controversial: Markets, Morals, and the President's Proposal for Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 12 (3):265-278.
John A. Robertson (1999). Ethics and Policy in Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):109-136.
Zubin Master & G. K. D. Crozier (2012). The Ethics of Moral Compromise for Stem Cell Research Policy. Health Care Analysis 20 (1):50-65.
Jeremy Sugarman (2010). Reflections on Governance Models for the Clinical Translation of Stem Cells. Journal of Law, Medicine and Ethics 38 (2):251-256.
O. Carter Snead (2012). The Law and Politics of Embryo Research in America. Human Reproduction and Genetic Ethics 17 (1):40-52.
Shelley Tremain (2006). Stemming the Tide of Normalisation: An Expanded Feminist Analysis of the Ethics and Social Impact of Embryonic Stem Cell Research. [REVIEW] Journal of Bioethical Inquiry 3 (1-2):33-42.
Added to index2011-07-12
Total downloads10 ( #154,179 of 1,101,947 )
Recent downloads (6 months)3 ( #128,846 of 1,101,947 )
How can I increase my downloads?